Loading clinical trials...

MTA and Biodentine in Pulpotomized Primary Molars | Clinical Trials | Clareo Health

UNKNOWNPhase 4NCT01591278

MTA and Biodentine in Pulpotomized Primary Molars

The objective of the study is to evaluate and compare, clinically and radiographically,the effects of MTA and Biodentine when used as pulp dressings following pulpotomy in human primary molars.

Lead sponsor: Cristina Cuadros•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Clinical and Radiographic Evaluation of Pulpotomies in Primary Molars Using Tricalcium Silicate Cements

NCT04902495 · Primary Molar Pulpotomy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 13, 2014Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment80

Start dateMar 2012

Last updatedNov 13, 2014

Condition

Primary Molar Pulpotomy

Locations shown

Universitat Internacional de Catalunya

Sant Cugat del Vallès, Barcelona

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 13, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions